Your browser doesn't support javascript.
loading
Maintenance versus discontinuation of androgen deprivation therapy during continuous or intermittent docetaxel administration in castration-resistant prostate cancer patients: A multicentre, randomised Phase III study by the Piemonte Oncology Network.
Bianchi, Susanna; Mosca, Alessandra; Dalla Volta, Alberto; Prati, Veronica; Ortega, Cinzia; Buttigliero, Consuelo; Fea, Elena; Vanella, Paola; Valcamonico, Francesca; Zamparini, Manuel; Sirotova, Zuzana; Chiappino, Isabella; Dal Canton, Orietta; Masini, Cristina; Sacco, Cosimo; Amoroso, Domenico; Montagnani, Francesco; Comandone, Alessandro; Bellissimo, Andrea R; Ciccone, Giovannino; Baier, Susanne; Gennari, Alessandra; Tucci, Marcello; Berruti, Alfredo.
Afiliação
  • Bianchi S; Medical Oncology Unit, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, ASST-Spedali Civili, Piazzale Spedali Civili 1, 25123, Brescia, Italy.
  • Mosca A; Multidisciplinary Oncology Outpatient Clinic, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy.
  • Dalla Volta A; Medical Oncology Unit, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, ASST-Spedali Civili, Piazzale Spedali Civili 1, 25123, Brescia, Italy.
  • Prati V; Multidisciplinary Oncology Outpatient Clinic, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy; Department of Medical Oncology, Ospedale S. Lazzaro Azienda Sanitaria Locale CN2, Alba-Bra, Cuneo, Italy.
  • Ortega C; Multidisciplinary Oncology Outpatient Clinic, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy; Department of Medical Oncology, Ospedale S. Lazzaro Azienda Sanitaria Locale CN2, Alba-Bra, Cuneo, Italy.
  • Buttigliero C; Department of Medical Oncology, University of Torino, San Luigi Gonzaga Hospital, Orbassano, Italy.
  • Fea E; Department of Medical Oncology, S Croce and Carle Teaching Hospital, Cuneo, Italy.
  • Vanella P; Department of Medical Oncology, S Croce and Carle Teaching Hospital, Cuneo, Italy.
  • Valcamonico F; Medical Oncology Unit, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, ASST-Spedali Civili, Piazzale Spedali Civili 1, 25123, Brescia, Italy.
  • Zamparini M; Medical Oncology Unit, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, ASST-Spedali Civili, Piazzale Spedali Civili 1, 25123, Brescia, Italy.
  • Sirotova Z; Unit of Medical Oncology, Aosta Regional Hospital, Aosta, Italy.
  • Chiappino I; Medical Oncology Unit, Azienda Ospedaliero Universitaria Città della Salute e della Scienza, Torino, Italy.
  • Dal Canton O; Medical Oncology Unit, Humanitas Gradenigo Hospital, Turin, Italy; Department of Medical Oncology, Azienda Sanitaria Locale Città di Torino, Turin, Italy.
  • Masini C; Medical Oncology Unit, Clinical Cancer Center, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
  • Sacco C; Department of Oncology, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy.
  • Amoroso D; Medical Oncology Unit, Azienda USL Toscana Nord-Ovest, Ospedale Versilia, Lido di Camaiore, Italy.
  • Montagnani F; Medical Oncology Unit, Azienda Sanitaria Locale Biella, Biella, Italy.
  • Comandone A; Medical Oncology Unit, Humanitas Gradenigo Hospital, Turin, Italy; Department of Medical Oncology, Azienda Sanitaria Locale Città di Torino, Turin, Italy.
  • Bellissimo AR; Unit of Clinical Epidemiology, Azienda Ospedaliero Universitaria Città Della Salute e Della Scienza di Torino and Centro di Prevenzione Oncologica Piemonte, Torino, Italy.
  • Ciccone G; Unit of Clinical Epidemiology, Azienda Ospedaliero Universitaria Città Della Salute e Della Scienza di Torino and Centro di Prevenzione Oncologica Piemonte, Torino, Italy.
  • Baier S; Medical Oncology Unit, Ospedale Centrale di Bolzano, 39100 Bolzano, Italy.
  • Gennari A; Division of Oncology, Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy.
  • Tucci M; Department of Medical Oncology, Cardinal Massaia Hospital, Asti, Italy.
  • Berruti A; Medical Oncology Unit, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, ASST-Spedali Civili, Piazzale Spedali Civili 1, 25123, Brescia, Italy. Electronic address: alfredo.berruti@unibs.it.
Eur J Cancer ; 155: 127-135, 2021 09.
Article em En | MEDLINE | ID: mdl-34371442
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias de Próstata Resistentes à Castração / Docetaxel / Antagonistas de Androgênios Tipo de estudo: Clinical_trials Limite: Aged / Humans / Male / Middle aged Idioma: En Revista: Eur J Cancer Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Itália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias de Próstata Resistentes à Castração / Docetaxel / Antagonistas de Androgênios Tipo de estudo: Clinical_trials Limite: Aged / Humans / Male / Middle aged Idioma: En Revista: Eur J Cancer Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Itália